Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists

The Lancet Respiratory Medicine

Volumn 5, Issue 3, 2017, Pages 162-164

  Nguyen, Dan Vinh ^a   Linderholm, Angela ^a   Haczku, Angela ^a   Kenyon, Nicholas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; LIRAGLUTIDE;

ASTHMA; CHRONIC INFLAMMATION; DRUG EFFECT; DYSLIPIDEMIA; EOSINOPHIL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC ASTHMA; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; RESPIRATORY TRACT INFLAMMATION; COMPLICATION;

ASTHMA; GLUCAGON-LIKE PEPTIDE 1; HUMANS; METABOLIC SYNDROME; OBESITY;

EID: 85013995763     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30051-6     Document Type: Note

References (15)

1. 1 Baffi, CW, Wood, L, Winnica, D, et al. Metabolic syndrome and the lung. Chest 149 (2016), 1525–1534.
2. 2 Holguin, F, Arginine and nitric oxide pathways in obesity-associated asthma. J Allergy (Cairo), 2013, 2013, 714595.
3. 3 Milutinovic, PS, Alcorn, JF, Englert, JM, Crum, LT, Oury, TD, The receptor for advanced glycation end products is a central mediator of asthma pathogenesis. Am J Pathol 181 (2012), 1215–1225.
4. 4 Singh, VP, Aggarwal, R, Singh, S, et al. Metabolic syndrome is associated with increased oxo-nitrative stress and asthma-like changes in lungs. PLoS One, 10, 2015, e0129850.
5. 5 Ojima, A, Ishibashi, Y, Matsui, T, et al. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol 182 (2013), 132–141.
6. 6 Ryan, D, Acosta, A, GLP-1 receptor agonists: nonglycemic clinical effects in weight loss and beyond. Obesity 23 (2015), 1119–1129.
7. 7 Richter, G, Feddersen, O, Wagner, U, Barth, P, Goke, R, Goke, B, GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am J Physiol 265 (1993), L374–L381.
8. 8 Zhu, T, Wu, XL, Zhang, W, Xiao, M, Glucagon like peptide-1 (GLP-1) modulates OVA-induced airway inflammation and mucus secretion involving a protein kinase A (PKA)-dependent nuclear factor-kappaB (NF-kappaB) signaling pathway in mice. Int J Mol Sci 16 (2015), 20195–20211.
9. 9 Rogliani, P, Calzetta, L, Capuani, B, et al. GLP1-R: a novel pharmacological target for treating human bronchial hyperresponsiveness. Am J Respir Cell Mol Biol 55 (2016), 804–814.
10. 10 Mitchell, PD, Salter, BM, Oliveria, JP, et al. Glucagon like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation. Clin Exp Allergy, 2016, 10.1111/cea.12860 published online Dec 8.
11. 11 Kenyon, NJ, Last, M, Bratt, JM, Kwan, VW, O'Roark, E, Linderholm, A, L-arginine supplementation and metabolism in asthma. Pharmaceuticals 4 (2011), 187–201.
12. 12 Kellow, NJ, Coughlan, MT, Effect of diet-derived advanced glycation end products on inflammation. Nutr Rev 73 (2015), 737–759.
13. 13 Watanabe, T, Asai, K, Fujimoto, H, Tanaka, H, Kanazawa, H, Hirata, K, Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 105 (2011), 519–525.
14. 14 Yao, L, Zhao, H, Tang, H, et al. The receptor for advanced glycation end products is required for beta-catenin stabilization in a chemical-induced asthma model. Br J Pharmacol 173 (2016), 2600–2613.
15. 15 Marso, SP, Daniels, GH, Brown-Frandsen, K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375 (2016), 311–322.